logo
New budget deal to put money in pockets of working families in CNY

New budget deal to put money in pockets of working families in CNY

Yahoo30-04-2025

SYRACUSE, N.Y. (WSYR-TV) — Governor Kathy Hochul is celebrating a 2026 New York State Budget deal that will put thousands of dollars back into the pockets of Central New York families.
According to Hochul, the first step is expanding New York's Child Tax Credit.
This will include giving 67,000 families in Central New York an annual tax credit of up to $1,000 per child under the age of four, and up to $500 per child from four through 16. This is the largest expansion of New York's child tax credit in history.
Hochul is also planning to cut taxes for more than 80% of all tax filers in Central New York and send the state's first-ever inflation refund checks.
'The cost of living is too damn high for Central New York families, so I promised to put more money in your pockets – and we got it done,' said Governor Hochul. 'Putting thousands of dollars back in the pockets of families means helping Central New Yorkers afford the rising costs of groceries, raising kids, and just enjoying life. When I said your family is my fight, I meant it – and I'll never stop fighting for you.'
Hochul's goal is to help families of all sizes and income levels across Central New York.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Baird Upgrades Urban Outfitters, Inc. (URBN) on Nuuly Growth
Baird Upgrades Urban Outfitters, Inc. (URBN) on Nuuly Growth

Yahoo

time33 minutes ago

  • Yahoo

Baird Upgrades Urban Outfitters, Inc. (URBN) on Nuuly Growth

Urban Outfitters, Inc. (NASDAQ:URBN) is among the 10 Best Growth Stocks Under $100 to Buy Now. Mark Altschwager, an analyst at Baird, raised the price target for Urban Outfitters, Inc. (NASDAQ:URBN) to $90 from $75, while elevating the rating from 'Neutral' to 'Outperform'. This price appreciation of 20% underscores the company's position for a turnaround. The company recently reported strong first-quarter results, with a 74% increase in net income stemming from margin improvement. The investors are closely monitoring the giant's subscription/rental business, Nuuly, which is anticipated to grow 43% to $540m this year. A frontline retail worker organizing apparel products in a store. To sum it up, Urban Outfitters, Inc. (NASDAQ:URBN) is a unique 'growth at a reasonable price' stock that is witnessing strong comp sales growth in each of its brands, and with even more room to grow via both price hikes and traffic increases. As long as the company is able to capitalize on Nuuly, we can expect it to show sustained momentum. Urban Outfitters, Inc. (NASDAQ:URBN) is a Pennsylvania-based fashion business that operates through three segments: Retail, Wholesale, and Subscription. Incepted in 1970, the company serves its customers directly through websites and retail stores, as well as social media and external sources. While the broader market delivered nearly 100% return in five years, URBN has exhibited a return of 295%. While we acknowledge the potential of URBN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

CompoSecure, Inc. (CMPO) CFO Tim Fitzsimmons to Retire After 13 Years
CompoSecure, Inc. (CMPO) CFO Tim Fitzsimmons to Retire After 13 Years

Yahoo

time33 minutes ago

  • Yahoo

CompoSecure, Inc. (CMPO) CFO Tim Fitzsimmons to Retire After 13 Years

CompoSecure, Inc. (NASDAQ:CMPO) is among the 10 Best Growth Stocks Under $100 to Buy Now. CompoSecure, Inc. (NASDAQ:CMPO) recently disclosed that Tim Fitzsimmons, the Chief Financial Officer, will be retiring after his 13-year tenure. The retirement is set to take effect once a successor is in place, anticipated no later than the start of 2026. To facilitate the smooth leadership transition, Fitzsimmons, who aided the company's transition from a family-owned business into a publicly listed company, will serve as a consultant. With his role as a 'proud shareholder', we can expect little to change in the company's growth avenues following his transition. It's safe to say that this leadership transition showcases a new chapter for the giant's growth prospects. A close up of a metal composite product, emphasizing its strength in design. The company reiterates its previously issued full-year 2025 guidance, anticipating mid-single-digit growth in not only consolidated net sales but also pro forma adjusted EBITDA. TD Cowen reaffirms its 'Buy' rating for the stock while maintaining a price target of $15. With its well-managed restructuring, we can expect CompoSecure, Inc. (NASDAQ:CMPO) to continue to leverage its involvement in the premium card market. CompoSecure, Inc. (NASDAQ:CMPO) is a New Jersey-based company that designs and produces metal, composite, and proprietary financial transaction cards in the United States and worldwide. With a mission to be a trusted technology partner, the company operates through two segments: Payment Card and Arculus. While we acknowledge the potential of CMPO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio

Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It

Yahoo

time41 minutes ago

  • Yahoo

Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It

Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past month, shares of this company have returned -2.4%, compared to the Zacks S&P 500 composite's +3.6% change. During this period, the Zacks Medical Info Systems industry, which Hims & Hers Health falls in, has gained 10.1%. The key question now is: What could be the stock's future direction? Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision. Here at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock. We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. For the current quarter, Hims & Hers Health is expected to post earnings of $0.17 per share, indicating a change of +183.3% from the year-ago quarter. The Zacks Consensus Estimate has changed +0.7% over the last 30 days. For the current fiscal year, the consensus earnings estimate of $0.73 points to a change of +170.4%. from the prior year. Over the last 30 days, this estimate has changed +0.6%. For the next fiscal year, the consensus earnings estimate of $1.04 indicates a change of +42.4% from what Hims & Hers Health is expected to report a year ago. Over the past month, the estimate has changed -0.6%. With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Hims & Hers Health. The chart below shows the evolution of the company's forward 12-month consensus EPS estimate: While earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth. In the case of Hims & Hers Health, the consensus sales estimate of $551.84 million for the current quarter points to a year-over-year change of +74.8%. The $2.34 billion and $2.9 billion estimates for the current and next fiscal years indicate changes of +58.5% and +23.8%, respectively. Hims & Hers Health reported revenues of $586.01 million in the last reported quarter, representing a year-over-year change of +110.7%. EPS of $0.2 for the same period compares with $0.05 a year ago. Compared to the Zacks Consensus Estimate of $538.09 million, the reported revenues represent a surprise of +8.9%. The EPS surprise was +66.67%. Over the last four quarters, Hims & Hers Health surpassed consensus EPS estimates two times. The company topped consensus revenue estimates each time over this period. Without considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects. Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is. The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued. Hims & Hers Health is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade. The facts discussed here and much other information on might help determine whether or not it's worthwhile paying attention to the market buzz about Hims & Hers Health. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Hims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store